Daniel Kenny

Biography

"Daniel Kenny joined OncoSil Medical in January 2015 with almost 30 years’ experience in the Global Pharmaceutical and Medical Device industry. Daniel is an accomplished and proven biopharmaceutical business leader and in his career he has developed and successfully driven business with industry leaders such as Roche, Allergan and Baxter working in Australia, EMEA and the US. Prior to joining OncoSil Medical, Daniel held the position of Chief Commercial Officer at ABIVAX a Paris based global biopharmaceutical company specialising in the development of novel vaccines and anti-virals. At Baxter Daniel served as Global Franchise Head Vaccines overseeing all Franchise Operations. Before this role, Daniel served as Vice President Baxter BioScience, EMEA with responsibility for all marketing and key business programmes in support of regional sales exceeding $1.9bio. Daniel also served with Roche as Global LifeCycle Leader for Roaccutance, a product generating sales in excess of CHF 1.1 bio (2002) assuming responsibility for all global strategic marketing and business development activities. Prior to this role he was International Medical Manager and Medical Science and Safety Team leader responsible for post NDA clinical development strategy and critical issue work ups for regulatory authorities. Daniel completed over 10 years in clinical research in the fields of Ophthalmology with the Royal Australian College of Ophthalmologists and the University of Sydney and HIV/AIDS research at the University of New South Wales, Sydney, Australia prior to joining the pharmaceutical industry. Daniel is a graduate in Physics from the University of New South Wales and has completed Executive business studies at both INSEAD and London Business School. He is a graduate of the Australian Institute of Physics and is a member of the Australian Institute of Company Directors"

Research Interest

Global Pharmaceutical and Medical Device industry